These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12784066)
1. Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. Baltás E; Trach V; Dobozy A; Kemény L Skin Pharmacol Appl Skin Physiol; 2003; 16(4):259-62. PubMed ID: 12784066 [TBL] [Abstract][Full Text] [Related]
2. Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice. Kemény L; Trach V; Dobozy A Arch Dermatol Res; 1996 Jul; 288(8):492-4. PubMed ID: 8844132 [No Abstract] [Full Text] [Related]
3. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs. Watanabe M; Osada H; Shimizu S; Goto S; Nagai M; Shirai J; Sasaki K; Shimoda M; Itoh H; Ohmori K Am J Vet Res; 2016 Sep; 77(9):969-75. PubMed ID: 27580108 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man. Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor. Dy LC; Pei Y; Travers JB J Biol Chem; 1999 Sep; 274(38):26917-21. PubMed ID: 10480902 [TBL] [Abstract][Full Text] [Related]
7. Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice. Amorim CZ; Martins MA; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1992 Jan; 211(1):29-33. PubMed ID: 1618265 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913 [TBL] [Abstract][Full Text] [Related]
10. Intensity and area increase of UVB-induced erythema: two variables used for studies of the influence of topically applied drugs. Juhlin L; Shroot B Acta Derm Venereol; 1993 Aug; 73(4):273-5. PubMed ID: 7904100 [TBL] [Abstract][Full Text] [Related]
11. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. Barber LA; Spandau DF; Rathman SC; Murphy RC; Johnson CA; Kelley SW; Hurwitz SA; Travers JB J Biol Chem; 1998 Jul; 273(30):18891-7. PubMed ID: 9668065 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. Adamus WS; Heuer H; Meade CJ; Frey G; Brecht HM Eur J Clin Pharmacol; 1988; 35(3):237-40. PubMed ID: 3181277 [TBL] [Abstract][Full Text] [Related]
13. Do oral carotenoids protect human skin against ultraviolet erythema, psoralen phototoxicity, and ultraviolet-induced DNA damage? Wolf C; Steiner A; Hönigsmann H J Invest Dermatol; 1988 Jan; 90(1):55-7. PubMed ID: 3335790 [TBL] [Abstract][Full Text] [Related]
14. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. Heuer HO J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings. Adamus WS; Heuer HO; Meade CJ; Schilling JC Clin Pharmacol Ther; 1990 Apr; 47(4):456-62. PubMed ID: 2328553 [TBL] [Abstract][Full Text] [Related]
17. Phloroglucinol inhibits ultraviolet B radiation-induced oxidative stress in the mouse skin. Piao MJ; Ahn MJ; Kang KA; Kim KC; Zheng J; Yao CW; Cha JW; Hyun CL; Kang HK; Lee NH; Hyun JW Int J Radiat Biol; 2014 Oct; 90(10):928-35. PubMed ID: 24716481 [TBL] [Abstract][Full Text] [Related]
18. Nanodiamonds protect skin from ultraviolet B-induced damage in mice. Wu MS; Sun DS; Lin YC; Cheng CL; Hung SC; Chen PK; Yang JH; Chang HH J Nanobiotechnology; 2015 May; 13():35. PubMed ID: 25947194 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. Brecht HM; Adamus WS; Heuer HO; Birke FW; Kempe ER Arzneimittelforschung; 1991 Jan; 41(1):51-9. PubMed ID: 1646613 [TBL] [Abstract][Full Text] [Related]
20. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]